Kizoo Portfolio Company Revel Pharmaceuticals Announces $8.4M Seed to Develop Repairing-Based Approaches to Reversing Aging
17. März 2022 08:00 ET
|
KIZOO Technology Capital GmbH
SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it has raised $8.4M in...